Campylobacter Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

Campylobacter Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Biotechnology

Report Description


Campylobacter infection is an abnormality observed in the digestive system caused by campylobacter bacteria. The most common sources of campylobacter infection are unpasteurized milk, raw poultry, or uncooked vegetables. Major symptoms of campylobacter infection include diarrhea, blood and mucus in stool, malaise, severe abdominal pain, nausea, fever, vomiting, and headache. On average, campylobacter infection lasts from two to 10 days. Campylobacter infection is diagnosed through laboratory tests of stool, body fluids, or tissue. Two types of tests are commonly performed: rapid test (analyzes the genetic material of campylobacter bacteria) and culture test (isolation of bacteria). Majorly, people affected with campylobacter infection are treated with antibiotics.

The global campylobacter diagnostics market is driven by several factors such as rise in population, sense of hygiene, diagnosis rate, cost of campylobacter infection diagnostic test, health care expenditure scenario, and presence of key market players. A study published in the Journal of Clinical Microbiology in 2016 revealed that the isolation and identification of the campylobacter infection from stool sample is the most challenging part in the campylobacter diagnosis test. Therefore, this market is likely to face challenges from sequencing of genetic materials of campylobacter infection, and un-automated data analysis during campylobacter detection method. R&D investments and technological advancements are likely to boost the growth of the global campylobacter diagnosis market during the forecast period.

Culture-based detection method is used to isolate and detect campylobacter infection from the sample. This method is cost-effective and requires no sophisticated instrument; however, it is time-consuming and has low-sensitivity. Rapid detection tests such as immunological or molecular techniques offer accurate result of campylobacter bacteria, although those tests are expensive as compared to culture based detection. Based on diagnosis method, the global campylobacter diagnosis market can be segmented into culture based diagnosis and rapid detection tests. Furthermore, the rapid detection tests can be segmented into immunological, molecular, and other methods. In terms of end-user, the market can be classified into hospitals, private laboratories, independent physician chambers, and others.

Geographically, the global campylobacter diagnostics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to the Centers for Disease Control and Prevention, an estimated 1.3 million people were affected with campylobacter infection in the U.S. in 2016. Nearly 200,000 confirmed cases were reported in Europe in 2014, with crude notification rate of 59.8 cases per 100,000 (reflecting an increase of 13% of the campylobacter notification rate in 2014 as compared to 2013). Significant infection rate, high diagnosis rate of campylobacter infection, well-established health care infrastructure, availability of medical reimbursement, and strong presence of key companies are likely to boost the growth of North America and Europe campylobacter diagnostics market in future. Several studies indicate that a significant number of people are affected by campylobacter infection in Asia Pacific. Around 5% to 15% of the total gastrointestinal cases in India and China in 2016 were campylobacter affected cases due to low sense of hygiene and poor sanitary system. The picture is quite shocking in Australia and New Zealand. Around 112.3 to 150.0 cases per 100,000 per year were affected in Australia and New Zealand in 2016. High number of campylobacter infected cases, developing medical infrastructure, high investment, and presence of key companies in Asia Pacific drive the campylobacter diagnostics market. Low awareness about campylobacter infection diagnosis and unfavorable medical reimbursements are the factors attributed to sluggish growth of the market in Latin America and Middle East & Africa.

Key players in the global campylobacter diagnostics market include Becton, Dickinson and Company, Meridian Bioscience, Inc., Thermo Fisher Scientific, BIOTECON Diagnostics, Agilent Technologies, Alere, QIAGEN, Roche Molecular Systems, Inc., Siemens Healthineers, Lonza, ZeptoMetrix, and Sequenom.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients